How Erivedge Is Designed To Work | Erivedge® (vismodegib)
Mechanistic Insights into the Generation and Transduction of Hedgehog Signaling: Trends in Biochemical Sciences
Vismodegib and the Hedgehog Pathway: A New Treatment for Basal Cell Carcinoma - ScienceDirect
Vismodegib | Nature Reviews Drug Discovery
Sonic Hedgehog pathway in the pathogenesis of basal cell carcinoma. | Download Scientific Diagram
IJMS | Free Full-Text | Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis | Acta Neuropathologica Communications | Full Text
Frontiers | Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response
Hedgehog Signaling Pathway Inhibitors for Basal Cell Carcinoma | SpringerLink
The story of vismodegib and basal cell carcinoma
Click Reaction as a Tool to Combine Pharmacophores: The Case of Vismodegib - Christodoulou - 2015 - ChemPlusChem - Wiley Online Library
Hedgehog signaling inhibitors in solid and hematological cancers
Vismodegib
Hedgehog signaling, vismodegib action, and acquired resistance | Download Scientific Diagram
Erivedge (vismodegib) – Treatment for Advanced Basal Cell Carcinoma - Clinical Trials Arena
Vismodegib: a promising drug in the treatment of basal cell carcinomas | Future Oncology
Vismodegib
View of Update on Hedgehog Pathway Inhibitor Therapy for Patients with Basal Cell Naevus Syndrome or High-frequency Basal Cell Carcinoma | Acta Dermato-Venereologica
The hedgehog pathway in triple‐negative breast cancer - Habib - 2016 - Cancer Medicine - Wiley Online Library
Vismodegib | C19H14Cl2N2O3S | CID 24776445 - PubChem
Vismodegib: A Review - ScienceDirect
Altered Hh signalling pathway and mechanism of action of vismodegib and... | Download Scientific Diagram
Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms | PLOS ONE
Vismodegib: a promising drug in the treatment of basal cell carcinomas | Future Oncology
Vismodegib (Erivedge) - Oncology Nurse Advisor
